Bionomics Ltd. ADR (NASDAQ: BNOX) is -79.86% lower on its value in year-to-date trading and has touched a low of $0.18 and a high of $1.76 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNOX stock was last observed hovering at around $0.28 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $0.30, the stock is -1.20% and -12.56% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.22 million and changing 5.30% at the moment leaves the stock -59.33% off its SMA200. BNOX registered -79.45% loss for a year compared to 6-month loss of -69.84%. The firm has a 50-day simple moving average (SMA 50) of $0.34772 and a 200-day simple moving average (SMA200) of $0.73703.
The stock witnessed a 38.80% gain in the last 1 month and extending the period to 3 months gives it a -53.70%, and is 5.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.15% over the week and 21.64% over the month.
Bionomics Ltd. ADR (BNOX) has around 24 employees, a market worth around $5.16M and $0.00M in sales. Distance from 52-week low is 68.36% and -83.06% from its 52-week high. The company has generated returns on investments over the last 12 months (-58.91%).
The EPS is expected to grow by 65.83% this year, but quarterly earnings will post -100.00% year-over-year.
The shares outstanding are 13.25M, and float is at 8.15M with Short Float at 4.72%.
The top institutional shareholder in the company is ARMISTICE CAPITAL, LLC with over 1.23 million shares valued at $0.94 million. The investor’s holdings represent 12.9314 of the BNOX Shares outstanding. As of 2024-06-30, the second largest holder is LYNX1 CAPITAL MANAGEMENT LP with 0.6 million shares valued at $0.46 million to account for 6.3212 of the shares outstanding. The other top investors are POINT72 ASSET MANAGEMENT, L.P. which holds 0.32 million shares representing 3.331 and valued at over $0.24 million, while UBS GROUP AG holds 0.3679 of the shares totaling 34897.0 with a market value of $26766.0.
